Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
IASO Bio acquires MediSix to expand CAR-T reach into T-cell malignancies
1+ hour, 36+ min ago (69+ words) Financial terms were not disclosed. The transaction is structured as a full acquisition, with MediSix operating as an integrated unit within IASO Bio following completion. No geographic restrictions on development rights were disclosed. Access the AllSci platform to explore the…...
Beyang bags USD 30m for AI-designed retinal, leukemia drugs
1+ day, 6+ hour ago (73+ words) Shanghai-based Beyang Therapeutics Co., Ltd., has closed an oversubscribed USD 30 million Series A financing round to advance its AI-driven drug discovery platform and two clinical-stage pipeline candidates targeting retinal disease and acute leukemia, the company said. Access the AllSci platform…...
Almirall taps CrystalO's AI platform to discover ion channel drugs for skin disease
3+ day, 1+ hour ago (427+ words) AllSci Barcelona-based Almirall, S.A. (ALM) and China-based Shenzhen CrystalO Biopharma Technology Co., Ltd. announced a collaboration and licensing agreement to discover and develop novel small-molecule ion channel modulators for skin diseases. The deal gives Almirall exclusive rights to develop, manufacture, and…...